Administration of erythropoietin in patients with myocardial infarction: does it make sense? An updated and comprehensive meta-analysis and systematic review
This systematic review with meta-analysis sought to determine protective effects of erythropoietin on clinical outcomes following percutaneous coronary intervention (PCI). Medline, Embase, Elsevier and Sciences online database as well as Google scholar literature were used for selecting appropriate...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
29 January 2015
|
| In: |
Cardiology research and practice
Year: 2015, Volume: 16, Issue: 3, Pages: 179-189 |
| ISSN: | 2090-0597 |
| DOI: | 10.1016/j.carrev.2015.01.008 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.carrev.2015.01.008 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1553838915000330 
|
| Author Notes: | Sadegh Ali-Hassan-Sayegh, Seyed Jalil Mirhosseini, Mahbube Tahernejad, Parisa Mahdavi, Fatemeh Haddad, Azadeh Shahidzadeh, Mohammad Reza Lotfaliani, Farbod Sedaghat-Hamedani, Elham Kayvanpour, Alexander Weymann, Anton Sabashnikov, Aron-Frederik Popov |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1725279088 | ||
| 003 | DE-627 | ||
| 005 | 20220818154955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200722s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.carrev.2015.01.008 |2 doi | |
| 035 | |a (DE-627)1725279088 | ||
| 035 | |a (DE-599)KXP1725279088 | ||
| 035 | |a (OCoLC)1341347309 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ali-Hassan-Sayegh, Sadegh |e VerfasserIn |0 (DE-588)1112350829 |0 (DE-627)866423249 |0 (DE-576)476578043 |4 aut | |
| 245 | 1 | 0 | |a Administration of erythropoietin in patients with myocardial infarction |b does it make sense? An updated and comprehensive meta-analysis and systematic review |c Sadegh Ali-Hassan-Sayegh, Seyed Jalil Mirhosseini, Mahbube Tahernejad, Parisa Mahdavi, Fatemeh Haddad, Azadeh Shahidzadeh, Mohammad Reza Lotfaliani, Farbod Sedaghat-Hamedani, Elham Kayvanpour, Alexander Weymann, Anton Sabashnikov, Aron-Frederik Popov |
| 264 | 1 | |c 29 January 2015 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.07.2020 | ||
| 520 | |a This systematic review with meta-analysis sought to determine protective effects of erythropoietin on clinical outcomes following percutaneous coronary intervention (PCI). Medline, Embase, Elsevier and Sciences online database as well as Google scholar literature were used for selecting appropriate studies with randomized controlled design. The effect sizes measured were odds ratio (OR) for categorical variables and weighted mean difference (WMD) with 95% confidence interval for calculating differences between mean values of duration of hospitalization in intervention and control groups. Values of P<0.1 for Q test or I2>50% indicated significant heterogeneity between the studies. The literature searches of all major databases retrieved 973 studies. After screening, a total of 15 trials that reported outcomes were identified. Pooled analysis was performed on left ventricular ejection fraction (WMD of −0.047; 95% CI: −0.912 to 0.819; P=0.9), left ventricular end diastolic volume (WMD of −0.363; 95% CI: −3.902 to 3.175; P=0.8), left ventricular end systolic volume (WMD of 0.346; 95% CI: −2.533 to 3.226; P=0.8), infarct size (WMD of −0.446; 95% CI: −2.352 to −1.460; P=0.6), stroke (OR of 2.1; 95% CI: 0.58 to 7.54; P=0.2), re-myocardial infarction (OR of 1.06; 95% CI: 0.52 to 2.185; P=0.8), heart failure (OR of 0.53; 95% CI: 0.259 to 1.105; P=0.09), mortality (OR of 0.56; 95% CI: 0.27 to 1.19; P=0.13), thrombosis (OR of 0.774; 95% CI: 0.41 to 1.45; P=0.4), major adverse cardiovascular events (OR of 0.926; 95% CI: 0.63 to 1.35; P=0.6). Short-term administration of EPO in patients with myocardial infarction (MI) undergoing PCI does not result in improvement in cardiac function, reduction of infarct size and all-cause mortality. Low dose EPO therapy may not be the choice of treatment for the patients with MI, while higher doses might be more effective. | ||
| 650 | 4 | |a Myocardial infarction | |
| 650 | 4 | |a Clinical outcome | |
| 650 | 4 | |a Erythropoietin | |
| 650 | 4 | |a Percutaneous coronary intervention | |
| 700 | 1 | |a Mirhosseini, Seyed Jalil |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tahernejad, Mahbube |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mahdavi, Parisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haddad, Fatemeh |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shahidzadeh, Azadeh |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lotfaliani, Mohammad Reza |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sedaghat-Hamedani, Farbod |d 1984- |e VerfasserIn |0 (DE-588)102545488X |0 (DE-627)722303106 |0 (DE-576)370367138 |4 aut | |
| 700 | 1 | |a Kayvanpour, Elham |d 1984- |e VerfasserIn |0 (DE-588)1033468983 |0 (DE-627)741277573 |0 (DE-576)381064247 |4 aut | |
| 700 | 1 | |a Weymann, Alexander |e VerfasserIn |0 (DE-588)1051122651 |0 (DE-627)785827102 |0 (DE-576)40592657X |4 aut | |
| 700 | 1 | |a Sabashnikov, Anton |d 1983- |e VerfasserIn |0 (DE-588)1012635643 |0 (DE-627)662254147 |0 (DE-576)345723619 |4 aut | |
| 700 | 1 | |a Popov, Aron-Frederik |d 1973- |e VerfasserIn |0 (DE-588)133221040 |0 (DE-627)691253188 |0 (DE-576)299704734 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiology research and practice |d [Hoboken, NJ : Wiley], 2009 |g 16(2015), 3, Seite 179-189 |h Online-Ressource |w (DE-627)605681252 |w (DE-600)2506187-2 |w (DE-576)309210291 |x 2090-0597 |7 nnas |a Administration of erythropoietin in patients with myocardial infarction does it make sense? An updated and comprehensive meta-analysis and systematic review |
| 773 | 1 | 8 | |g volume:16 |g year:2015 |g number:3 |g pages:179-189 |g extent:11 |a Administration of erythropoietin in patients with myocardial infarction does it make sense? An updated and comprehensive meta-analysis and systematic review |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.carrev.2015.01.008 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1553838915000330 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200722 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1051122651 |a Weymann, Alexander |m 1051122651:Weymann, Alexander |d 910000 |d 910200 |e 910000PW1051122651 |e 910200PW1051122651 |k 0/910000/ |k 1/910000/910200/ |p 10 | ||
| 998 | |g 1033468983 |a Kayvanpour, Elham |m 1033468983:Kayvanpour, Elham |d 910000 |d 910100 |e 910000PK1033468983 |e 910100PK1033468983 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 102545488X |a Sedaghat-Hamedani, Farbod |m 102545488X:Sedaghat-Hamedani, Farbod |d 910000 |d 910100 |e 910000PS102545488X |e 910100PS102545488X |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 999 | |a KXP-PPN1725279088 |e 3727906634 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 22.07.2020"],"language":["eng"],"person":[{"given":"Sadegh","family":"Ali-Hassan-Sayegh","role":"aut","display":"Ali-Hassan-Sayegh, Sadegh"},{"display":"Mirhosseini, Seyed Jalil","role":"aut","family":"Mirhosseini","given":"Seyed Jalil"},{"given":"Mahbube","role":"aut","family":"Tahernejad","display":"Tahernejad, Mahbube"},{"given":"Parisa","display":"Mahdavi, Parisa","role":"aut","family":"Mahdavi"},{"role":"aut","family":"Haddad","display":"Haddad, Fatemeh","given":"Fatemeh"},{"given":"Azadeh","role":"aut","family":"Shahidzadeh","display":"Shahidzadeh, Azadeh"},{"given":"Mohammad Reza","display":"Lotfaliani, Mohammad Reza","family":"Lotfaliani","role":"aut"},{"given":"Farbod","display":"Sedaghat-Hamedani, Farbod","role":"aut","family":"Sedaghat-Hamedani"},{"given":"Elham","display":"Kayvanpour, Elham","family":"Kayvanpour","role":"aut"},{"display":"Weymann, Alexander","family":"Weymann","role":"aut","given":"Alexander"},{"given":"Anton","display":"Sabashnikov, Anton","role":"aut","family":"Sabashnikov"},{"given":"Aron-Frederik","display":"Popov, Aron-Frederik","role":"aut","family":"Popov"}],"id":{"eki":["1725279088"],"doi":["10.1016/j.carrev.2015.01.008"]},"recId":"1725279088","type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"29 January 2015"}],"name":{"displayForm":["Sadegh Ali-Hassan-Sayegh, Seyed Jalil Mirhosseini, Mahbube Tahernejad, Parisa Mahdavi, Fatemeh Haddad, Azadeh Shahidzadeh, Mohammad Reza Lotfaliani, Farbod Sedaghat-Hamedani, Elham Kayvanpour, Alexander Weymann, Anton Sabashnikov, Aron-Frederik Popov"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Cardiology research and practice","title":"Cardiology research and practice"}],"part":{"extent":"11","year":"2015","pages":"179-189","issue":"3","text":"16(2015), 3, Seite 179-189","volume":"16"},"pubHistory":["2009 -"],"note":["Gesehen am 21.02.23"],"language":["eng"],"disp":"Administration of erythropoietin in patients with myocardial infarction does it make sense? An updated and comprehensive meta-analysis and systematic reviewCardiology research and practice","origin":[{"publisher":"Wiley] ; Hindawi","publisherPlace":"[Hoboken, NJ ; New York, NY","dateIssuedKey":"2024","dateIssuedDisp":"2024-"}],"id":{"issn":["2090-0597"],"zdb":["2506187-2"],"eki":["605681252"]},"recId":"605681252","type":{"media":"Online-Ressource","bibl":"periodical"}}],"physDesc":[{"extent":"11 S."}],"title":[{"subtitle":"does it make sense? An updated and comprehensive meta-analysis and systematic review","title_sort":"Administration of erythropoietin in patients with myocardial infarction","title":"Administration of erythropoietin in patients with myocardial infarction"}]} | ||
| SRT | |a ALIHASSANSADMINISTRA2920 | ||